Brian Custer

Summary

Affiliation: Blood Systems Research Institute
Country: USA

Publications

  1. pmc Outpatient red blood cell transfusion payments among patients on chronic dialysis
    Matthew Gitlin
    Amgen, Inc, One Amgen Center Drive, Thousand Oaks, CA, USA
    BMC Nephrol 13:145. 2012
  2. ncbi request reprint Epidemiologic and laboratory findings from 3 years of testing United States blood donors for Trypanosoma cruzi
    Brian Custer
    Blood Systems Research Institute, San Francisco, California 94118, USA
    Transfusion 52:1901-11. 2012
  3. pmc Demographics of successful, unsuccessful and deferral visits at six blood centers over a 4-year period
    Brian Custer
    Blood Systems Research Institute and UCSF, San Francisco, California 94118, USA
    Transfusion 52:712-21. 2012
  4. pmc Adverse reactions and other factors that impact subsequent blood donation visits
    Brian Custer
    Blood Systems Research Institute and UCSF, San Francisco, California 94118, USA
    Transfusion 52:118-26. 2012
  5. doi request reprint The cost-effectiveness of pathogen reduction technology as assessed using a multiple risk reduction model
    Brian Custer
    Blood Systems Research Institute, San Francisco, California 94118, USA
    Transfusion 50:2461-73. 2010
  6. ncbi request reprint The consequences of temporary deferral on future whole blood donation
    Brian Custer
    Blood Systems Research Institute, 270 Masonic Avenue, San Francisco, CA 94118, USA
    Transfusion 47:1514-23. 2007
  7. pmc Donor return after temporary deferral
    Brian Custer
    Blood Systems Research Institute and the University of California at San Francisco, San Francisco, California 94118, USA
    Transfusion 51:1188-96. 2011
  8. doi request reprint Associations between West Nile virus infection and symptoms reported by blood donors identified through nucleic acid test screening
    Brian Custer
    Blood Systems Research Institute, University of California, San Francisco, USA
    Transfusion 49:278-88. 2009
  9. doi request reprint Cost-effectiveness analysis: what it really means for transfusion medicine decision making
    Brian Custer
    Blood Systems Research Institute, San Francisco, CA St Michael s Hospital, Toronto, Ontario, Canada
    Transfus Med Rev 23:1-12. 2009
  10. ncbi request reprint Quantifying losses to the donated blood supply due to donor deferral and miscollection
    Brian Custer
    Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, Washington, USA
    Transfusion 44:1417-26. 2004

Collaborators

Detail Information

Publications40

  1. pmc Outpatient red blood cell transfusion payments among patients on chronic dialysis
    Matthew Gitlin
    Amgen, Inc, One Amgen Center Drive, Thousand Oaks, CA, USA
    BMC Nephrol 13:145. 2012
    ..Our objective was to examine the economic burden for payers when chronic dialysis patients receive outpatient RBC transfusions...
  2. ncbi request reprint Epidemiologic and laboratory findings from 3 years of testing United States blood donors for Trypanosoma cruzi
    Brian Custer
    Blood Systems Research Institute, San Francisco, California 94118, USA
    Transfusion 52:1901-11. 2012
    ..The objective of this study was to report the results of routine testing and risk factor data from allogeneic blood donors...
  3. pmc Demographics of successful, unsuccessful and deferral visits at six blood centers over a 4-year period
    Brian Custer
    Blood Systems Research Institute and UCSF, San Francisco, California 94118, USA
    Transfusion 52:712-21. 2012
    ..The demographics of successful (SV), unsuccessful (UV; meaning a nonuseable unit), and deferred (DV) donor visits over a 4-year period were investigated using Retrovirus Epidemiology Donor Study (REDS)-II databases...
  4. pmc Adverse reactions and other factors that impact subsequent blood donation visits
    Brian Custer
    Blood Systems Research Institute and UCSF, San Francisco, California 94118, USA
    Transfusion 52:118-26. 2012
    ..The importance of adverse reactions in terms of donor safety recently has received significant attention, but their role in subsequent donation behavior has not been thoroughly investigated...
  5. doi request reprint The cost-effectiveness of pathogen reduction technology as assessed using a multiple risk reduction model
    Brian Custer
    Blood Systems Research Institute, San Francisco, California 94118, USA
    Transfusion 50:2461-73. 2010
    ..Because of the potential broad-spectrum risk reduction capability of PRT, the health economics of PRT could be an important consideration in decision making for this technology...
  6. ncbi request reprint The consequences of temporary deferral on future whole blood donation
    Brian Custer
    Blood Systems Research Institute, 270 Masonic Avenue, San Francisco, CA 94118, USA
    Transfusion 47:1514-23. 2007
    ..The consequences of temporary deferral are not well understood. This study sought to investigate blood donor return after deferral expiration...
  7. pmc Donor return after temporary deferral
    Brian Custer
    Blood Systems Research Institute and the University of California at San Francisco, San Francisco, California 94118, USA
    Transfusion 51:1188-96. 2011
    ..Studies have found that deferral negatively impacts future donor return. However, the applicability of these findings across centers has not been established...
  8. doi request reprint Associations between West Nile virus infection and symptoms reported by blood donors identified through nucleic acid test screening
    Brian Custer
    Blood Systems Research Institute, University of California, San Francisco, USA
    Transfusion 49:278-88. 2009
    ..Little data are available on subsequent manifestations of WNV-specific disease outcomes in viremic donors...
  9. doi request reprint Cost-effectiveness analysis: what it really means for transfusion medicine decision making
    Brian Custer
    Blood Systems Research Institute, San Francisco, CA St Michael s Hospital, Toronto, Ontario, Canada
    Transfus Med Rev 23:1-12. 2009
    ....
  10. ncbi request reprint Quantifying losses to the donated blood supply due to donor deferral and miscollection
    Brian Custer
    Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, Washington, USA
    Transfusion 44:1417-26. 2004
    ..Donors are deferred for multiple reasons. Losses related to disease marker rates are well established. Donor and donation losses for other reasons, however, have not been extensively quantified...
  11. ncbi request reprint Triggers for switching from minipool testing by nucleic acid technology to individual-donation nucleic acid testing for West Nile virus: analysis of 2003 data to inform 2004 decision making
    Brian Custer
    Blood Systems Research Institute, San Francisco, California 94118, USA
    Transfusion 44:1547-54. 2004
    ..Strategies were investigated for the application of limited ID-NAT capacity in 2004...
  12. ncbi request reprint Global epidemiology of hepatitis B virus
    Brian Custer
    Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA, USA
    J Clin Gastroenterol 38:S158-68. 2004
    ..Preventing the most severe HBV disease consequences in infected individuals, such as cirrhosis and hepatocellular carcinoma, will require appropriate therapeutic agents...
  13. ncbi request reprint Community blood supply model: development of a new model to assess the safety, sufficiency, and cost of the blood supply
    Brian Custer
    Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, USA
    Med Decis Making 25:571-82. 2005
    ..However, as a result of increasingly stringent screening measures, one of the greatest threats may be an insufficient supply. The balance between safety and adequacy of the blood supply has not received enough attention...
  14. ncbi request reprint The cost-effectiveness of screening the U.S. blood supply for West Nile virus
    Brian Custer
    Blood Systems Research Institute, University of California, San Francisco, CA 94118 4417, USA
    Ann Intern Med 143:486-92. 2005
    ..The spread of West Nile virus across North America and evidence of transmission by transfusion prompted the U.S. Food and Drug Administration to encourage the development of methods to screen the blood supply...
  15. pmc West Nile virus infections projected from blood donor screening data, United States, 2003
    Michael P Busch
    Blood Systems Research Institute, San Francisco, California 94118, USA
    Emerg Infect Dis 12:395-402. 2006
    ..In addition to preventing transfusion-transmitted WNV infection, donor screening can serve as a tool to monitor seasonal incidence in the general population...
  16. doi request reprint Cost-effectiveness of screening the US blood supply for Trypanosoma cruzi
    Maria Agapova
    Blood Systems Research Institute, San Francisco, California 94117, USA
    Transfusion 50:2220-32. 2010
    ..Component-specific strategies are based on screening platelet-containing donations...
  17. pmc Tregs control the development of symptomatic West Nile virus infection in humans and mice
    Marion C Lanteri
    Blood Systems Research Institute, San Francisco, California 94118, USA
    J Clin Invest 119:3266-77. 2009
    ..Together, these results suggest that higher levels of peripheral Tregs after infection protect against severe WNV disease in immunocompetent animals and humans...
  18. doi request reprint Prevalence of human immunodeficiency virus RNA and antibody in first-time, lapsed, and repeat blood donations across five international regions and relative efficacy of alternative screening scenarios
    Roberta Bruhn
    Blood Systems Research Institute, Lelie Research, San Francisco, California, Paris, France University of British Columbia, Canada
    Transfusion 53:2399-412. 2013
    ..Residual risk and efficacy of several screening scenarios were estimated for first time, lapsed and repeat donations...
  19. pmc Motivation and social capital among prospective blood donors in three large blood centers in Brazil
    Thelma T Goncalez
    Department of Epidemiology, Blood Systems Research Institute, San Francisco, California 94118, USA
    Transfusion 53:1291-301. 2013
    ..Our study examines the association between motivation factors (altruism, self-interest, and response to direct appeal) and social capital (cognitive and structural) across three large blood centers in Brazil...
  20. pmc Analysis of donor deferral at three blood centers in Brazil
    Thelma T Goncalez
    Blood Systems Research Institute, San Francisco, California the Fundação Pró Sangue Hemocentro de São Paulo, Sao Paulo, Brazil
    Transfusion 53:531-8. 2013
    ..Examination of the donor deferrals at different centers provides insights into the role that deferrals play in transfusion safety...
  21. pmc Vasovagal reactions in whole blood donors at three REDS-II blood centers in Brazil
    Thelma T Goncalez
    Blood Systems Research Institute, 270 Masonic Avenue, San Francisco, CA 94118, USA
    Transfusion 52:1070-8. 2012
    ..Donors are offered snacks and fluids before donating and are required to consume a light meal after donation. For these reasons the frequency of reactions may be different than those observed in other countries...
  22. pmc Association between HLA class I and class II alleles and the outcome of West Nile virus infection: an exploratory study
    Marion C Lanteri
    Blood Systems Research Institute, San Francisco, California, United States of America
    PLoS ONE 6:e22948. 2011
    ..West Nile virus (WNV) infection is asymptomatic in most individuals, with a minority developing symptoms ranging from WNV fever to serious neuroinvasive disease. This study investigated the impact of host HLA on the outcome of WNV disease...
  23. doi request reprint Faint and prefaint reactions in whole-blood donors: an analysis of predonation measurements and their predictive value
    Thomas B Wiltbank
    United Blood Services, and Blood Systems, Scottsdale, Arizona and Blood Systems Research Institute, San Francisco, California, USA
    Transfusion 48:1799-808. 2008
    ....
  24. doi request reprint Bacterial detection in apheresis platelets: blood systems experience with a two-bottle and one-bottle culture system
    Leon L Su
    United Blood Services and Blood Systems, Scottsdale, Arizona and Blood Systems Research Institute, San Francisco, California, USA
    Transfusion 48:1842-52. 2008
    ..Collection of 7-day PLTs using two-bottle cultures began in April 2006. This study compares our experience using both systems...
  25. ncbi request reprint Modeling red cell procurement with both double-red-cell and whole-blood collection and the impact of European travel deferral on units available for transfusion
    Erin Madden
    School of Public Health, University of California, Berkeley, California, USA
    Transfusion 47:2025-37. 2007
    ..To show the importance of including 2RBCs in predictive models of the blood supply, an existing whole-blood (WB) model was updated to include 2RBC collection and then run to simulate the effect of vCJD deferral on total RBC availability...
  26. ncbi request reprint Two-year experience with aerobic culturing of apheresis and whole blood-derived platelets
    Steven H Kleinman
    Blood Systems Research Institute, San Francisco, California, USA
    Transfusion 46:1787-94. 2006
    ..Throughout its system of regional centers, Blood Systems implemented culture based bacterial testing with a standardized protocol for both apheresis and whole blood-derived platelets (PLTs)...
  27. pmc Increased all-cause, liver, and cardiac mortality among hepatitis C virus-seropositive blood donors
    Anne M Guiltinan
    Blood Systems Research Institute, San Francisco, CA 94118, USA
    Am J Epidemiol 167:743-50. 2008
    ..High rates of mortality from drug/alcohol and trauma/suicide causes are likely due to lifestyle factors and may be at least partially preventable...
  28. doi request reprint Interventions to reduce the vasovagal reaction rate in young whole blood donors
    Peter Tomasulo
    Blood Systems, Inc, Scottsdale, Arizona 85257, USA
    Transfusion 51:1511-21. 2011
    ..There have been multiple reports concerning the predictors of fainting reactions in blood donors, but few attempts to reduce the rates of fainting reactions with concomitant rigorous attempts to monitor the success of the interventions...
  29. doi request reprint Delayed adverse reactions to blood donation
    Hany Kamel
    Blood Systems, Inc, Scottsdale, Arizona 85257, USA
    Transfusion 50:556-65. 2010
    ..Blood donation is safe, but a small proportion of donors have delayed and/or off-site reactions that have the potential to lead to serious injury. This retrospective study sought to identify risk factors for delayed reactions (DRs)...
  30. ncbi request reprint Safety and donor acceptance of an abbreviated donor history questionnaire
    Hany T Kamel
    Blood Systems, Inc, Scottsdale, Arizona 85257, USA
    Transfusion 46:1745-53. 2006
    ..Surveys have shown donor dissatisfaction with the duration of the donation process and repetitive questioning. An abbreviated donor history questionnaire (AQ) may improve satisfaction, but must be safe...
  31. pmc Undisclosed human immunodeficiency virus risk factors identified through a computer-based questionnaire program among blood donors in Brazil
    Paula Fraiman Blatyta
    Fundação Pró Sangue Hemocentro de São Paulo, Sao Paulo, SP, Brazil Blood Systems Research Institute, San Francisco, California Westat, Rockville, Maryland Fundação Hemorio, Rio de Janeiro, RJ, Brazil Fundação HEMOPE, Recife, PE, Brazil Fundação Hemominas, Belo Horizonte, MG, Brazil Department of Infectious Diseases, Medical School, University of Sao Paulo, Sao Paulo, SP, Brazil University of California at San Francisco, San Francisco, California
    Transfusion 53:2734-43. 2013
    ..Audio computer-assisted structured interview (ACASI) has been shown to increase self-reporting of risk behaviors...
  32. pmc Blood transfusion utilization and recipient survival at Hospital das Clinicas in São Paulo, Brazil
    Thelma T Goncalez
    Blood Systems Research Institute, 270 Masonic Avenue, San Francisco, CA 94118, USA
    Transfusion 52:729-38. 2012
    ..The goals of this analysis were: 1) to describe blood utilization according to clinical diagnoses and patient characteristics and 2) to determine the factors associated with survival of blood recipients...
  33. doi request reprint Risk assessment and cost-effectiveness/utility analysis
    Michael Busch
    Blood Systems Research Institute, San Francisco, CA, USA
    Biologicals 37:78-87. 2009
    ..This set of articles will introduce risk assessment and cost-effectiveness methodologies and discuss recent applications of these methods in transfusion medicine...
  34. ncbi request reprint Economic analyses of blood safety and transfusion medicine interventions: a systematic review
    Brian Custer
    Blood Centers of the Pacific, San Francisco, CA 94118 4417, USA
    Transfus Med Rev 18:127-43. 2004
    ....
  35. doi request reprint If the permanent deferral were lifted would men who have sex with men want to donate blood, and if so, who would be eligible?
    Geoffrey A Belanger
    San Jose State University, San Jose, California Stanford Blood Center, Palo Alto, California HIV Epidemiology Section, San Francisco Department of Public Health, San Francisco, California Epidemiology and Biostatistics and Laboratory Medicine, University of California at San Francisco, San Francisco, California Blood Systems Research Institute, San Francisco, California
    Transfusion 53:2729-33. 2013
    ..This study assesses whether MSM have donated and would be interested in donating if the US exclusion policy were removed and who would be eligible to donate if the policy were modified to a temporary or lower-risk deferral criterion...
  36. pmc Acquisition of GB virus type C and lower mortality in patients with advanced HIV disease
    Farnaz Vahidnia
    Blood Systems Research Institute, Epidemiology, San Francisco, CA 94118, USA
    Clin Infect Dis 55:1012-9. 2012
    ..Open questions are the presence and the direction of any causal relationship between GBV-C infection and HIV disease markers in the context of highly active antiretroviral therapy (HAART)...
  37. pmc Elevations in IL-10, TNF-alpha, and IFN-gamma from the earliest point of HIV Type 1 infection
    Philip J Norris
    Blood Systems Research Institute, San Francisco, California 94118, USA
    AIDS Res Hum Retroviruses 22:757-62. 2006
    ..Cytokine alterations occurred within 7 days of detectable HIV-1 viremia, emphasizing the need to study the earliest events of infection...
  38. pmc Loss of T cell responses following long-term cryopreservation
    Rachel E Owen
    Blood Systems Research Institute, 270 Masonic Avenue, San Francisco, CA 94118, USA
    J Immunol Methods 326:93-115. 2007
    ..Long-term cryopreservation, however, may lead to the loss of CD4(+) T cell responses and mild skewing of T cell phenotypic marker expression...
  39. pmc Persistence of West Nile virus-specific antibodies in viremic blood donors
    Harry E Prince
    Focus Diagnostics, Cypress, California, USA
    Clin Vaccine Immunol 14:1228-30. 2007
    ..At 1-year of follow-up, 17% of the donors (n = 23) were positive for WNV IgM, 57% were positive for WNV IgA, and 100% were positive for WNV IgG...
  40. ncbi request reprint Strategies for testing blood donors for West Nile virus
    Susan L Stramer
    Transfusion 46:2036-7. 2006